Akcea Therapeutics Inc. priced its initial public offering well below the expected range late Thursday, with shares expected to trade Friday. Akcea priced its 15.6 million share offering at $8 a share, according to IPO Boutique. In late June, the biotech drug developer had forecast an IPO pricing range of $12 to $14 a share for an offering of 9.6 million shares. Akcea shares begin trade on Friday on the Nasdaq under the ticker symbol “AKCA”.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News